Sun Pharma Laboratories Ltd has announced plans to establish a new greenfield formulations manufacturing facility in Madhya Pradesh, marking a strategic expansion of its domestic production capabilities. 

The investment underscores the company’s ongoing effort to strengthen its supply chain for key therapeutic products and to meet growing demand across Indian and global markets. 

The new plant is expected to feature advanced automation and quality-control systems aligned with international regulatory standards.

Industry observers note that Sun Pharma’s expansion reflects a broader trend of pharmaceutical majors increasing local capacity to reduce dependence on imported raw materials and intermediates. 

The facility is also likely to support enhanced research-linked manufacturing, especially in areas where the company holds strong market share. 

Once operational, it is expected to improve turnaround times for high-volume formulations and support new product introductions.